A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch

Documenti analoghi

• A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
  di: Bachert, Claus, et al.
  Pubblicazione: (2013)
• A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
  di: Hellings, Peter, et al.
  Pubblicazione: (2015)
• A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
  di: Hellings, Peter, et al.
  Pubblicazione: (2013)
• A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
  di: Bousquet, Jean, et al.
  Pubblicazione: (2013)
• A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
  di: Price, David, et al.
  Pubblicazione: (2013)